The Subscription-based Functional Mushroom Company has established a significant consumer base in the U.S. VANCOUVER, BC, Dec. 20, 2021 /CNW/ – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP)(the “Company” or “Havn Life”), a biotechnology company developing natural health products and innovative therapies to support central nervous system health and enhance the capabilities of the mind…

Source

Previous articlePsychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles As Lock-Up Expiry Date Arrives; UT Austin Launches Psychedelics Centre
Next articleTwo esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities